Abeona Therapeutics Inc (ABEO) returns
Abeona Therapeutics returns over 10 years
$1,000 invested in Abeona Therapeutics ten years ago was worth $24.68 at the close on October 30, 2026, with dividends reinvested: an average return of -30.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -17.1% | — | $828.57 | -0.9% |
| 3 months | -32.8% | — | $672.33 | +2.1% |
| Year to date | -17.5% | — | $825.43 | +11.7% |
| 1 year | -14.4% | — | $856.30 | +12.4% |
| 3 years | +14.8% | +4.7% | $1,148 | +88.5% |
| 5 years | -78.6% | -26.5% | $214.21 | +76.0% |
| 10 years | -97.5% | -30.9% | $24.68 | +316.6% |
Abeona Therapeutics return by calendar year
| Year | ABEO | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -17.5% | +11.7% | -29.1% |
| 2025 | -5.4% | +17.7% | -23.1% |
| 2024 | +11.2% | +24.9% | -13.7% |
| 2023 | +62.7% | +26.2% | +36.5% |
| 2022 | -63.4% | -18.2% | -45.3% |
| 2021 | -78.5% | +28.7% | -107.3% |
| 2020 | -52.0% | +18.4% | -70.4% |
| 2019 | -54.2% | +31.2% | -85.4% |
| 2018 | -55.0% | -4.6% | -50.4% |
| 2017 | +226.8% | +21.7% | +205.1% |
| 2016 | +44.3% | +12.0% | +32.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ABEO financials
No forecast, no recommendation. This page describes Abeona Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.